Archive: August 2025
Feature
Use of Terlipressin in Liver Transplant Candidates
Abstract: The use of terlipressin in the treatment of hepatorenal syndrome type 1 (HRS-1) in patients with advanced cirrhosis wait-listed for liver transplant (LT) has been […]
Feature
Eosinophils Beyond the Esophagus: A Review of Non-EoE Eosinophilic Gastrointestinal Diseases
Abstract: For eosinophilic esophagitis (EoE), the most well researched of the eosinophilic gastrointestinal diseases (EGIDs), there is a plethora of knowledge for its diagnosis and management; […]
MASH in Focus
Fibroblast Growth Factor 21 Agonists for the Treatment of Patients With Metabolic Dysfunction-Associated Steatohepatitis
G&H Why are fibroblast growth factor 21 agonists being studied for the treatment of metabolic dysfunction-associated steatohepatitis? PN Fibroblast growth factor 21 (FGF21) agonists are being […]
Advances in IBS
Capsule Technologies for Disorders of Gut-Brain Interaction: Hope or Hype?
G&H What are the advantages and limitations of capsule technologies/wireless motility capsule testing? BK Capsule technology is extremely exciting because it is an evolution in diagnostics. […]
Advances in IBD
How to Approach Immune Checkpoint Inhibitor Enterocolitis
G&H What are the similarities and differences between immune checkpoint inhibitor enterocolitis and inflammatory bowel disease in terms of etiology, clinical presentation, and endoscopic presentation? YW […]
Advances in Upper GI Disorders
On-Demand Therapy for Gastroesophageal Reflux Disease
G&H What are the benefits of transitioning to a noncontinuous dosing strategy, specifically on-demand therapy, for gastroesophageal reflux disease? RF On-demand therapy offers several advantages for […]
Letter From the Editor
Letter From the Editor: Exploring the Use of Terlipressin in Candidates for Liver Transplant
Should terlipressin be used in liver transplant candidates? This question is explored in a feature article in this month’s issue of the journal Gastroenterology & Hepatology. […]